A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.

Creators: Gasparini G; Torino F; Ueno T; Cascinu S; Troiani T; BALLESTRERO, ALBERTO; Berardi R; Shishido J; Yoshizawa A; Mori Y; Nagayama S; Morosini P; Toi M.

Others:: Gasparini, G; Torino, F; Ueno, T; Cascinu, S; Troiani, T; Ballestrero, Alberto; Berardi, R; Shishido, J; Yoshizawa, A; Mori, Y; Nagayama, S; Morosini, P; Toi, M.

Additional details